NYSE:USPH U.S. Physical Therapy Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding U.S. Physical Therapy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $81.99 -2.99 (-3.52 %) (As of 09/23/2020 12:00 AM ET) Add Compare Share Today's Range$81.99Now: $81.99▼$85.5150-Day Range$83.42MA: $90.14▼$94.1552-Week Range$45.13Now: $81.99▼$148.48Volume71,044 shsAverage Volume119,084 shsMarket Capitalization$1.05 billionP/E Ratio34.16Dividend Yield0.73%Beta1.22 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.Read More Beat the Market (BTM) Rank™ 1.2 Analyst's Opinion Consensus RatingU.S. Physical Therapy has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $90.00, U.S. Physical Therapy has a forecasted upside of 9.8% from its current price of $81.99.Amount of Analyst CoverageU.S. Physical Therapy has only been the subject of 1 research reports in the past 90 days. Previous Next 2.1 Community Rank Outperform VotesU.S. Physical Therapy has received 225 “outperform” votes. (Add your “outperform” vote.)Underperform VotesU.S. Physical Therapy has received 321 “underperform” votes. (Add your “underperform” vote.)Community SentimentU.S. Physical Therapy has received 58.79% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote “Outperform” if you believe USPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend YieldU.S. Physical Therapy has a dividend yield of 0.73%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthU.S. Physical Therapy does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of U.S. Physical Therapy is 21.99%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 23.31% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, U.S. Physical Therapy insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $542,090.00 in company stock.Percentage Held by InsidersOnly 2.00% of the stock of U.S. Physical Therapy is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for U.S. Physical Therapy are expected to grow by 46.15% in the coming year, from $1.82 to $2.66 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of U.S. Physical Therapy is 34.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.04.Price to Earnings Ratio vs. SectorThe P/E ratio of U.S. Physical Therapy is 34.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.47.Price to Earnings Growth RatioU.S. Physical Therapy has a PEG Ratio of 4.17. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioU.S. Physical Therapy has a P/B Ratio of 4.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.2Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.36 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Health services Sub-IndustryHealth Care Facilities SectorMedical Current SymbolNYSE:USPH Previous Symbol CUSIP90337L10 CIK885978 Webwww.usph.com Phone713-297-7000Debt Debt-to-Equity Ratio0.13 Current Ratio1.05 Quick Ratio1.05Price-To-Earnings Trailing P/E Ratio34.16 Forward P/E Ratio45.05 P/E Growth4.17 Sales & Book Value Annual Sales$481.97 million Price / Sales2.18 Cash Flow$3.25 per share Price / Cash Flow25.25 Book Value$18.92 per share Price / Book4.33Profitability EPS (Most Recent Fiscal Year)$2.82 Net Income$40.04 million Net Margins6.64% Return on Equity13.36% Return on Assets5.55%Miscellaneous Employees5,400 Outstanding Shares12,843,000Market Cap$1.05 billion Next Earnings Date11/5/2020 (Estimated) OptionableOptionable $81.99 -2.99 (-3.52 %) (As of 09/23/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive USPH News and Ratings via Email Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter. U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions How has U.S. Physical Therapy's stock been impacted by Coronavirus (COVID-19)? U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, USPH stock has decreased by 12.0% and is now trading at $81.99. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of U.S. Physical Therapy? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for U.S. Physical Therapy. When is U.S. Physical Therapy's next earnings date? U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for U.S. Physical Therapy. How were U.S. Physical Therapy's earnings last quarter? U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, August, 6th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of ($0.18) by $1.03. The company had revenue of $83.86 million for the quarter, compared to the consensus estimate of $87.24 million. U.S. Physical Therapy had a return on equity of 13.36% and a net margin of 6.64%. U.S. Physical Therapy's quarterly revenue was down 33.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.81 EPS. View U.S. Physical Therapy's earnings history. How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy? U.S. Physical Therapy declared a quarterly dividend on Friday, February 28th. Stockholders of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 annualized dividend and a yield of 1.56%. The ex-dividend date is Thursday, March 12th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.30. View U.S. Physical Therapy's dividend history. What price target have analysts set for USPH? 3 equities research analysts have issued 1 year target prices for U.S. Physical Therapy's shares. Their forecasts range from $80.00 to $100.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $90.00 in the next twelve months. This suggests a possible upside of 9.8% from the stock's current price. View analysts' price targets for U.S. Physical Therapy. Who are some of U.S. Physical Therapy's key competitors? Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), The Ensign Group (ENSG), Acadia Healthcare (ACHC), Select Medical (SEM), Tenet Healthcare (THC), National HealthCare (NHC), Hanger (HNGR), Brookdale Senior Living (BKD), Community Health Systems (CYH), Five Star Senior Living (FVE), Capital Senior Living (CSU) and Encompass Health (EHC). View all competitors. What other stocks do shareholders of U.S. Physical Therapy own? Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), IBM (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC). Who are U.S. Physical Therapy's key executives? U.S. Physical Therapy's management team includes the following people: Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)Mr. Jon C. Bates, VP & Corp. Controller What is U.S. Physical Therapy's stock symbol? U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH." Who are U.S. Physical Therapy's major shareholders? U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (12.46%), Vanguard Group Inc. (6.96%), Wasatch Advisors Inc. (4.33%), Riverbridge Partners LLC (2.81%), Boston Trust Walden Corp (2.39%) and Granite Investment Partners LLC (1.63%). Company insiders that own U.S. Physical Therapy stock include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View institutional ownership trends for U.S. Physical Therapy. Which institutional investors are selling U.S. Physical Therapy stock? USPH stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Copeland Capital Management LLC, Goldman Sachs Group Inc., Vanguard Group Inc., BRYN MAWR TRUST Co, SG Americas Securities LLC, Envestnet Asset Management Inc., and Russell Investments Group Ltd.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner. View insider buying and selling activity for U.S. Physical Therapy. Which institutional investors are buying U.S. Physical Therapy stock? USPH stock was bought by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Granite Investment Partners LLC, Boston Trust Walden Corp, Peregrine Capital Management LLC, Kayne Anderson Rudnick Investment Management LLC, FMR LLC, Fenimore Asset Management Inc., and Tygh Capital Management Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson. View insider buying and selling activity for U.S. Physical Therapy. How do I buy shares of U.S. Physical Therapy? Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is U.S. Physical Therapy's stock price today? One share of USPH stock can currently be purchased for approximately $81.99. How big of a company is U.S. Physical Therapy? U.S. Physical Therapy has a market capitalization of $1.05 billion and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 5,400 workers across the globe. What is U.S. Physical Therapy's official website? The official website for U.S. Physical Therapy is www.usph.com. How can I contact U.S. Physical Therapy? U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected] This page was last updated on 9/24/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
